FREEDMAN EDWARD D. enters PANDION THERAPEUTICS, INC. with 52.11K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 7/16/2020ACC: 0000899243-20-019432
Officer· Chief Operating Officer
Since Jul 2020
52.11K
Baseline shares
100% direct
52.11K
Direct ownership
1 position
2.35K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned52.11K
Total
52.11K direct52.11K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 52.11K | Direct |
| Total | 52.11K | 52.11K direct |
Derivative Holdings1
Series B Preferred Stock
DirectUnderlying security
Common Stock
Underlying shares
2.35K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
2.35K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series B Preferred Stock Direct | Common Stock | — | — | 2.35K | N/A | |
| Total | 2.35K | 0.00 | ||||